Moran Eye Institute spin-out company providing intraocular drug delivery platform to treat major eye diseases.
iVeena, LLC. is developing novel drug delivery solutions for treatment of common eye diseases that lead to blindness. These devices will increase patient comfort, compliance, and convenience and at the same time increase drug performance with improved sustained delivery.
iVeena will move its solutions into the market via a number of strategic channel partnerships each focused on specific drug-device combinations.